Dr. Farzad Kobarfard, Pharm.D., Ph.D., is a distinguished pharmaceutical and medicinal chemist renowned for his expertise in analytical chemistry, mass spectrometry, and chromatography. Currently serving as Chairman at GelEntroCeutics Inc. and Scientific Adviser of CREM Co Labs in Canada and a Full Professor at Shahid Beheshti University of Medical Sciences (SBMU) in Tehran, Dr. Kobarfard has an extensive academic and professional history.
He earned his Pharm.D. in Pharmaceutical Sciences from Tehran University of Medical Sciences (1988) and completed his Ph.D. in Medicinal Chemistry at the University of the Sciences in Philadelphia, USA (2000), graduating with a perfect GPA of 4.0. His doctoral research, under Prof. Joel M. Kauffman, focused on synthesizing new fluorinated antimicrobial agents.
Dr. Kobarfard’s professional career spans over three decades and includes key roles such as Technical Director at Iran’s Doping Control Laboratory, Director of the Neonatal Metabolic Disorder Screening Lab, and Head of Central Research Laboratories at SBMU. His work is internationally recognized, notably in neonatal screening, pesticide residue analysis, and food contaminant detection, leveraging advanced analytical methods like LC-MS and GC-MS.
He is credited with numerous scientific publications, books, and patents, including innovations in pharmaceutical formulations and analytical methodologies. Dr. Kobarfard actively contributes to scientific communities through memberships in prominent organizations like the American Chemical Society and American Association of Pharmaceutical Scientists, and editorial roles in reputed journals such as the Iranian Journal of Pharmaceutical Research and the Iran Pharmacopoeia.
Committed to advancing pharmaceutical sciences and analytical methodologies, Dr. Kobarfard continues to pioneer research and innovation in his field.
Recent Comments